Pacira BioSciences
PCRX
PCRX
260 hedge funds and large institutions have $1.65B invested in Pacira BioSciences in 2023 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 87 increasing their positions, 92 reducing their positions, and 38 closing their positions.
Holders
260
Holders Change
–
Holders Change %
0%
% of All Funds
3.81%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
40
Increased
87
Reduced
92
Closed
38
Calls
$12.8M
Puts
$5.96M
Net Calls
+$6.81M
Net Calls Change
+$6.53M
Top Buyers
| 1 |
1
Pacer Advisors
Malvern,
Pennsylvania
|
$35.1M |
| 2 |
2
Morgan Stanley
New York
|
$46.2M |
| 3 |
3
BlackRock
New York
|
$274M |
| 4 |
FCM
4
Frontier Capital Management
Boston,
Massachusetts
|
$70.3M |
| 5 |
5
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$8.32M |
